Previous Article | Next Article ![]()
Infection and Immunity, July 2000, p. 4363-4367, Vol. 68, No. 7
Departments of
Microbiology,1 Clinical
Bacteriology,2 Clinical
Immunology,3 and Oral
Biology,4 Umeå University, S-901 87 Umeå,
Sweden, and Department of Bacteriology, Graduate School of
Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan5
Received 4 November 1999/Returned for modification 3 February
2000/Accepted 1 April 2000
Cytolysin A (ClyA) is a newly discovered cytolytic protein of
Escherichia coli K-12 that mediates a hemolytic phenotype.
We show here that highly purified ClyA and ClyA-expressing E. coli were cytotoxic and apoptogenic to fresh as well as cultured
human and murine monocytes/macrophages.
Recently it was discovered that a
chromosomal gene denoted clyA (also referred to as
sheA and hlyE) in Escherichia coli
K-12 encodes a novel hemolytic protein (5, 20, 21, 24, 25, 28; Y. Mizunoe and B. E. Uhlin, Abstr. 34th Intersci.
Conf. Antimicrob. Agents Chemother., abstr. B37, 1994). However, the gene product, the 34-kDa cytolysin A (ClyA) protein, does not seem to
be expressed under normal laboratory conditions. This normally latent
clyA gene can be activated either by mutation in the
hns locus or by overexpression of several putative
regulatory genes (5, 8, 9, 19-21, 24, 25, 28;
Mizunoe and Uhlin, 34th ICAAC). Both purified ClyA and ClyA-expressing
E. coli are able to lyse erythrocytes from several mammalian
species in both solid and liquid media, and we recently found that the
protein is cytotoxic to macrophages grown in tissue culture
(5, 8, 9, 19-21, 24, 25, 28; Mizunoe and Uhlin,
34th ICAAC). Those findings prompted us to further investigate the
interaction of ClyA-producing bacteria and purified ClyA with mammalian
cells.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Cytocidal and Apoptotic Effects of the ClyA Protein from
Escherichia coli on Primary and Cultured Monocytes
and Macrophages

![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References

View larger version (25K):
[in a new window]
FIG. 1.
Cytotoxicity as manifested by LDH release from
murine macrophages J774. About 2 × 104 cells were
seeded each well in 96-well plates and treated with highly purified
ClyA or infected at different MOIs with ClyA-expressing or vector
control E. coli as described elsewhere (17, 18,
24). Killing was assayed at several time intervals and expressed
as percent cytotoxicity. Data are means ± standard deviations
(n = 4) from one representative experiment of three.
The E. coli strains used here do not have endogenous LDH
activity when grown aerobically. (A) Dose-dependent toxicity of
purified ClyA. Cells were pretreated with PMA as described elsewhere
(24). (B) Cytotoxicity of ClyA-expressing E. coli
MC1061/pYMZ80 compared with its plasmid vector control MC1061/pUC18 at
an MOI of 100. (C) Infection dose-dependent toxicity of ClyA-expressing
E. coli (MOI of 100 versus 10).
Cytotoxic effects of purified ClyA protein and ClyA-expressing E. coli on fresh or cultured human and murine monocytes/macrophages. Cell morphology changes and detachment from culture plates are conventional and useful indicators to monitor bacterial cytotoxicity. We recently described that highly purified ClyA can detach J774 macrophages from culture plates and change their cell morphology (24). In the present study, we extended our cytotoxicity measurements to other types of host cells by using a neutral red uptake assay (2) and a quantitative lactate dehydrogenase (LDH) release assay based on the fact that LDH is a strictly cytoplasmic enzyme and its presence in the culture medium reflects the disruption of the host cell plasma membrane (16).
The macrophage cell lines J774 (murine) and U937 (human) were maintained and treated as described previously (17, 18, 24, 26, 27). Human polymorphonuclear leukocytes and monocytes were isolated following a standardized procedure as described previously (11, 13). Highly purified ClyA preparations were obtained from E. coli K-12 cells carrying clone pYMZ80 (24; S. N. Wai and B. E. Uhlin, unpublished data). Proteins were diluted in complete medium and sterilized by filtration through a 0.22-µm-pore-size membrane (Schleicher & Schuell FD 030/3). J774 cells, polymorphonuclear leukocytes, or monocytes were treated with purified and filtrated ClyA in 200 µl (total volume) of cell medium. In some experiments, cells were pretreated with phorbol 12-myristate 13-acetate (PMA; Sigma) as described before (24). For testing the effect of cytochalasin D (4) on cytotoxicity, cells were pretreated with 1 µg of cytochalasin D (Sigma) ml
1 for 30 min
before bacterial infection, and cytochalasin D was maintained
throughout the experiment. Treatment of the bacteria and eukaryotic
cells with cytochalasin D at the above concentration did not
significantly reduce cell or bacterial viability (data not shown).
E. coli strains MC1061/pUC18 and MC1061/pYMZ80 were used as described elsewhere (24). J774 cells were infected
as described elsewhere (17, 18, 24) with bacteria at a
multiplicity of infection (MOI) of 100, unless otherwise indicated.
As shown in Fig. 1, LDH release was both ClyA concentration and
bacterial infection dose (i.e., MOI) dependent. ClyA at 20 µg
ml
1 caused more than 20% LDH release after 2 h of
treatment, while no detectable LDH release came from cells treated with
one-sixth as much ClyA (Fig. 1A). LDH release remained at baseline
level for the vector control MC1061/pUC18, whereas the ClyA-expressing strain MC1061/pYMZ80 was cytotoxic to J774 macrophages at each time
interval tested (Fig. 1B and C). MC1061/pYMZ80 showed
approximately one-third as much cytotoxicity at an MOI
of 10 compared with that at an MOI of 100, at both 2 and 4 h
postinfection (p.i.). The cytotoxicity was even greater at 6 h
p.i. and approached a level similar to that at the higher MOI (Fig.
1C). The kinetics of cytotoxicity within 6 h of treatment over
three time intervals are shown in Fig. 1.
The effect of ClyA on viability of human primary monocytes was
monitored using a neutral red uptake assay as described before (2,
11, 13). The viability of freshly isolated human peripheral monocytes showed a dose-related decline after treatment with ClyA for
20 h (Fig. 2), and the effect was
similar to that seen with cultured J774 macrophages. Exposure of human
peripheral blood lymphocytes or monocytes to 10 µg of ClyA
ml
1 for 1 h caused about 20% LDH release, which is
comparable to the cytotoxicity level of ClyA on cultured macrophages
(Fig. 1A).
|
Apoptosis judged by DNA fragmentation of macrophages infected with ClyA-expressing E. coli or treated with purified ClyA. The biochemical hallmark of apoptosis is the cleavage of chromatin into nucleosomal fragments, resulting in multimers of 180 to 200 bp (15, 30). However, it has been reported that necrotic cells may have irregular DNA fragmentation and generate higher-molecular-weight DNA fragments (23). We used three complementary assays to determine whether the predominant macrophage cell death induced by these treatments was due to apoptosis.
Photometric determination of the histone-associated DNA fragments released by the treated cells was performed with the sensitive cell death detection enzyme-linked immunosorbent assay (ELISA; Boehringer Mannheim GmbH) according to the manufacturer's instructions and as described elsewhere (18). Substrate reaction time was 15 min. Both ClyA-expressing E. coli MC1061/pYMZ80 (Fig. 3A and C) and purified ClyA (Fig. 3B) induced strong signals representing small DNA fragments released to the cell supernatant.
|
|
1 in Tris-acetate-EDTA buffer (pH 8.2). DNA was
visualized by UV light and photographed. As evidenced by
electrophoresis of genomic DNA, a nucleosome ladder pattern of
DNA degradation was observed in J774 cells infected with MC1061/pYMZ80
but not in J774 cells infected with the vector control MC1061/pUC18
(Fig. 5). It was also evident that
cytochalasin D did not inhibit the apoptogenic property of
MC1061/pYMZ80 on J774 cells (Fig. 5, lane 4) under the conditions used
here.
|
Conclusions. Taken together, our data demonstrate that purified ClyA and a ClyA-expressing E. coli strain were cytotoxic to both human and murine macrophages in a dose- and time-dependent way and induced a massive amount of apoptosis as determined by several assays showing host cell DNA fragmentation. Further studies will hopefully elucidate the precise mechanisms of ClyA-induced apoptosis of host cells. Our findings that this protein, in addition to being merely a hemolysin, is more widely cytocidal and has the capacity to induce macrophage apoptosis should prompt studies of how ClyA might contribute to pathogenicity of certain E. coli strains.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to Guangqian Zhou for supplying a sample of PMA.
This work was supported by grants from the Swedish Natural Science Research Council, the Swedish Medical Research Council, the Swedish Institute, the Wenner-Gren Foundations, and the Göran Gustafsson Foundation for Research in Natural Sciences and Medicine.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology, Umeå University, S-901 87 Umeå, Sweden. Phone: 46 90 785 6731. Fax: 46 90 772630. E-mail: bernt.eric.uhlin{at}micro.umu.se.
Permanent address: Priority Laboratory of Molecular Medical
Bacteriology of Ministry of Public Health, Institute of Epidemiology and Microbiology, Chinese Academy of Preventive Medicine, Beijing, China.
Editor: J. T. Barbieri
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Anderson, P. 1997. Kinase cascades regulating entry into apoptosis. Microbiol. Mol. Biol. Rev. 61:33-46[Abstract]. |
| 2. | Borenfreud, E., and J. A. Puerener. 1985. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol. Lett. 24:119-124[CrossRef][Medline]. |
| 3. | Chen, Y. J., and A. Zychlinsky. 1994. Apoptosis induced by bacterial pathogens. Microb. Pathog. 17:203-212[CrossRef][Medline]. |
| 4. |
Cooper, J. A.
1987.
Effects of cytochalasin and phalloidin on actin.
J. Cell Biol.
105:1473-1478 |
| 5. | del Castillo, I., S. C. Leal, F. Moreno, and I. del Castillo. 1997. The Escherichia coli K-12 sheA gene encodes a 34-kDa secreted haemolysin. Mol. Microbiol. 25:107-115[CrossRef][Medline]. |
| 6. |
Fernandez-Prada, C.,
B. D. Tall,
S. E. Elliott,
D. L. Hoover,
J. P. Nataro, and M. M. Venkatesan.
1998.
Hemolysin-positive enteroaggregative and cell-detaching Escherichia coli strains cause oncosis of human monocyte-derived macrophages and apoptosis of murine J774 cells.
Infect. Immun.
66:3918-3924 |
| 7. |
Gavrieli, Y.,
Y. Sherman, and S. A. Ben-Sasson.
1992.
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
J. Cell Biol.
119:493-501 |
| 8. | Gómez-Gómez, J. M., J. Blázquez, F. Baquero, and J. L. Martínez. 1996. hns mutant unveils the presence of a latent haemolytic activity in Escherichia coli K-12. Mol. Microbiol. 19:909-910[CrossRef][Medline]. |
| 9. | Green, J., and M. L. Baldwin. 1997. The molecular basis for the differential regulation of the hlyE-encoded haemolysin of Escherichia coli by FNR and HlyX lies in the improved activating region 1 contact of HlyX. Microbiology 143:3785-3793[Abstract]. |
| 10. |
Herrmann, M.,
H.-M. Lorenz,
R. Voll,
W. Woith, and J. R. Kalden.
1994.
A rapid and simple method for the isolation of apoptotic DNA fragments.
Nucleic Acids Res.
22:5506-5507 |
| 11. | Holm, A., S. Kalfas, and S. E. Holm. 1993. Killing of Actinobacillus actinomycetemcomitans and Haemophilus aphrophilus by human polymorphonuclear leukocytes in serum and saliva. Oral Microbiol. Immunol. 8:134-140[Medline]. |
| 12. |
Iwase, M.,
E. T. Lally,
P. Berthold,
H. M. Korchak, and N. S. Taichman.
1990.
Effects of cations and osmotic protectants on cytolytic activity of Actinobacillus actinomycetemcomitans.
Infect. Immun.
58:1782-1788 |
| 13. | Johansson, A., L. Hänström, and S. Kalfas. Inhibition of Actinobacillus actinomycetemcomitans leukotoxicity by bacterial proteases. Oral Microbiol. Immunol., in press. |
| 14. |
Jonas, D.,
B. Schultheis,
C. Klas,
P. H. Krammer, and S. Bhakdi.
1993.
Cytocidal effects of E. coli hemolysin on human T lymphocytes.
Infect. Immun.
61:1715-1721 |
| 15. | Kerr, J. F. R., A. H. Wyllie, and A. R. Currie. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26:239-257[Medline]. |
| 16. | Korzeniewski, C., and D. M. Callewaert. 1983. An enzyme-release assay for natural cytotoxicity. J. Immunol. Methods 64:313-320[CrossRef][Medline]. |
| 17. |
Lai, X.-H.,
S.-Y. Wang, and B. E. Uhlin.
1999.
Expression of cytotoxicity by potential pathogens in the standard Escherichia coli collection of reference (ECOR) strains.
Microbiology
145:3295-3303 |
| 18. | Lai, X.-H., J.-G. Xu, S. Melgar, and B. E. Uhlin. 1999. An apoptotic response by J774 macrophage cells is common upon infection with diarrheagenic Escherichia coli. FEMS Microbiol. Lett. 172:29-34[CrossRef][Medline]. |
| 19. |
Libby, S. J.,
W. Goebel,
A. Ludwig,
N. Buchmeier,
F. Bowe,
F. C. Fang,
D. G. Guiney,
J. G. Songer, and F. Heffron.
1994.
A cytolysin encoded by Salmonella is required for survival within macrophages.
Proc. Natl. Acad. Sci. USA
91:489-493 |
| 20. | Ludwig, A., S. Bauer, R. Benz, B. Bergmann, and W. Goebel. 1999. Analysis of the SlyA-controlled expression, subcellular localization and pore-forming activity of a 34 kDa haemolysin (ClyA) from Escherichia coli K-12. Mol. Microbiol. 31:557-567[CrossRef][Medline]. |
| 21. | Ludwig, A., C. Tengel, S. Bauer, A. Bubert, R. Benz, H. J. Mollenkopf, and W. Goebel. 1995. SlyA, a regulatory protein from Salmonella typhimurium, induces a haemolytic and pore-forming protein in Escherichia coli. Mol. Gen. Genet. 249:474-484[CrossRef][Medline]. |
| 22. | McConkey, D. J., and S. Orrenius. 1994. Signal transduction pathways to apoptosis. Trends Cell Biol. 4:370-374[CrossRef][Medline]. |
| 23. | Ojcius, D. M., A. Zychlinsky, L. M. Zheng, and J. D.-E. Young. 1991. Ionophore-induced apoptosis: role of DNA fragmentation and calcium fluxes. Exp. Cell Res. 197:43-49[CrossRef][Medline]. |
| 24. | Oscarsson, J., Y. Mizunoe, L. Li, X.-H. Lai, Å. Wieslander, and B. E. Uhlin. 1999. Molecular analysis of the cytolytic protein ClyA (SheA) from Escherichia coli. Mol. Microbiol. 32:1226-1238[CrossRef][Medline]. |
| 25. | Oscarsson, J., Y. Mizunoe, B. E. Uhlin, and D. J. Haydon. 1996. Induction of haemolytic activity in Escherichia coli by the slyA gene product. Mol. Microbiol. 20:191-199[Medline]. |
| 26. | Ralph, P., and I. Nakoinz. 1975. Phagocytosis and cytolysis by a macrophage tumor and its cloned cell line. Nature 257:393-394[CrossRef][Medline]. |
| 27. | Sundström, C., and K. Nilsson. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U937). Int. J. Cancer 17:565-577[Medline]. |
| 28. | Uhlin, B. E., and Y. Mizunoe. 1994. Expression of a novel contact-hemolytic activity by E. coli. J. Cell Biochem. 18A:71. |
| 29. | Wallace, A. J., T. J. Stillman, A. Atkins, S. J. Jamieson, P. A. Bullough, J. Green, and P. J. Artymiuk. 2000. E. coli hemolysin E (HlyE, ClyA, SheA): X-ray crystal structure of the toxin and observation of membrane pores by electron microscopy. Cell 100:265-276[CrossRef][Medline]. |
| 30. | Wyllie, A. H. 1980. Glucocorticoid induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|